These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1898707

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Low serum transglutaminase in patients with intestinal lymphoma and alpha-chain disease.
    D'Argenio G, Sorrentini I, Ciacci C, Mazzacca G.
    Am J Gastroenterol; 1990 Dec; 85(12):1654-5. PubMed ID: 1979203
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Changes in serum diamine oxidase activity during chemotherapy in patients with hematological malignancies.
    Tsujikawa T, Uda K, Ihara T, Inoue T, Andoh A, Fujiyama Y, Bamba T.
    Cancer Lett; 1999 Dec 01; 147(1-2):195-8. PubMed ID: 10660106
    [Abstract] [Full Text] [Related]

  • 30. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
    Mrabti H, Raiss G, Raissouni S, Tazi el M, Inghaouen H, El Ghissassi I, Errihani H.
    Presse Med; 2011 Nov 01; 40(11):995-1000. PubMed ID: 21458210
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Large bowel tumors and diamine oxidase (DAO) activity in patients: a new approach for risk group identification.
    Mennigen R, Kusche J, Krakamp B, Elbers A, Amoei B, Kessebohm M, Sommer H.
    Agents Actions; 1988 Apr 01; 23(3-4):351-3. PubMed ID: 3134802
    [Abstract] [Full Text] [Related]

  • 34. Recurrent urticaria and reduced diamine oxidase activity.
    Lessof MH, Gant V, Hinuma K, Murphy GM, Dowling RH.
    Clin Exp Allergy; 1990 Jul 01; 20(4):373-6. PubMed ID: 2115815
    [Abstract] [Full Text] [Related]

  • 35. Large bowel tumor promotion by diamine oxidase inhibition: animal model and clinical aspects.
    Kusche J, Menningen R, Leisten L, Krakamp B.
    Adv Exp Med Biol; 1988 Jul 01; 250():745-52. PubMed ID: 3151234
    [Abstract] [Full Text] [Related]

  • 36. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse.
    Hilsden RJ, Meddings JB, Hardin J, Gall DG, Sutherland LR.
    Inflamm Bowel Dis; 1999 May 01; 5(2):85-91. PubMed ID: 10338376
    [Abstract] [Full Text] [Related]

  • 37. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
    Vaiphei K, Kumari N, Sinha SK, Dutta U, Nagi B, Joshi K, Singh K.
    World J Gastroenterol; 2006 Jun 14; 12(22):3602-8. PubMed ID: 16773719
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
    Zahner J, Kirchner T, Ott G, Schneider W.
    Schweiz Med Wochenschr; 1994 Jul 12; 124(27-28):1227-31. PubMed ID: 8052827
    [Abstract] [Full Text] [Related]

  • 40. Immunoproliferative small intestinal disease (IPSID) in Thailand.
    Pramoolsinsap C, Kurathong S, Atichartakarn V, Nitiyanand P.
    Southeast Asian J Trop Med Public Health; 1993 Mar 12; 24(1):11-7. PubMed ID: 8362283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.